Cancer screening

“Screening is the systematic application of a test or inquiry, to identify individuals at sufficient risk of a specific disorder to benefit from further investigation or direct preventive action, among persons who have not sought medical attention on account of symptoms of that disorder.”1

[1]  N J Wald,et al.  Guidance on terminology , 2006, Journal of medical screening.

[2]  Bruce S. Ling,et al.  A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer , 2002, American Journal of Gastroenterology.

[3]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[4]  M. Law.  The number needed to screen—an adaptation of the number needed to treat , 2001, Journal of medical screening.

[5]  A. Richardson.  Screening and the number needed to treat , 2001, Journal of medical screening.

[6]  A. Raffle,et al.  Information about screening – is it to achieve high uptake or to ensure informed choice? , 2001, Health expectations : an international journal of public participation in health care and health policy.

[7]  L. Irwig,et al.  Telling people about screening programmes and screening test results: how can we do it better? , 2000, Journal of medical screening.

[8]  J. Nottingham.  Women must be given fully informed information about cervical screening , 1999, BMJ.

[9]  G H Guyatt,et al.  Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. , 1999, JAMA.

[10]  P. Babb,et al.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. , 1999, BMJ.

[11]  S. Fletcher.  Evidence-based screening: what kind of evidence is needed? , 1998, ACP journal club.

[12]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[13]  D. Torgerson,et al.  An economic view of high compliance as a screening objective , 1994, BMJ.

[14]  P. Glasziou,et al.  Meta-analysis adjusting for compliance: the example of screening for breast cancer. , 1992, Journal of clinical epidemiology.

[15]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[16]  D M Eddy,et al.  Comparing benefits and harms: the balance sheet. , 1990, JAMA.

[17]  T. To,et al.  Women's attitudes to screening after participation in the national breast screening study. A questionnaire survey , 1990, Cancer.

[18]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[19]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[20]  G. Friedman,et al.  Screening in chronic disease , 2004, Cancer Causes & Control.

[21]  A. Culyer,et al.  False-negative results in screening programmes: systematic review of impact and implications. , 2000, Health technology assessment.

[22]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .